exercise and cancer outcomes assoc prof sandi hayes qut, ihbi, school of public health
TRANSCRIPT
Exercise and Cancer Outcomes
Assoc Prof Sandi Hayes
QUT, IHBI, School of Public Health
CRICOS No. 00213J
Reduced Functional
status
Gastro-intestinal
side effects
depression
neuropathy
fatigue
depression
arthralgia
sleeping difficulties
poor body image
changes in BC
Quality and quantity of survival
Survivorship concerns
Function, quality of life and survival
Fatigue
depression
Functional status
CIPNArthralgias
Bone outcomes
CV late effects
Survivorship concerns: common, do not sit in isolation and persist
Schmitz et al; Cancer, 2012, 118(8):S2217-2225
(n=160) Post-diagnosis
6m 12m 18m 6y
0 symptoms 60 (37.5) 80 (50.0) 92 (57.5) 68 (42.5)
1 symptom 43 (26.9) 38 (23.8) 28 (17.5) 41 (25.6)
2 symptoms 26 (16.3) 22 (13.8) 21 (13.1) 27 (16.9)
3+ symptoms 31 (19.4) 20 (12.5) 19 (12.0) 24 (15.0)
No cancer(%)
< 5 year cancer
survivor (%)
5+ year cancer survivor (%)
A: Any physical restriction 13 31 31
B: Any limitation in physical performance
21 53 54
Survivorship concerns: associated with cancer and its treatment
Ness et al, AEP, 2006, 16:197
Limitations in physical performance and participation restrictions:
• Impacts all aspects of quality of life• Associated with increased health care costs• May influence survival
Individual Impact Public health Impact
So what?
Concerns following cancer
• improves the function of all of our physiological systems• being physically active =
– Reduces risk of specific cancers by up to 60%– Reduces risk of heart disease and hypertension by 40%– Reduces risk of stroke by 27%– Reduces risk of type II diabetes by 58%– Is twice as effective in treating type II diabetes than insulin– Decreases depression as effectively as prozac or
behavioural therapy• Physical inactivity = greater risk of dying than smoking, obesity,
hypertension, high cholesterol
Relevance of exercise?
Exercise and cancer outcomes
Preservation or improvements:
Reductions:
• Muscle mass, strength, power• Cardiorespiratory fitness• Physical function• Physical activity levels• Range of motion• Immune function• Chemotherapy completion rates• Body image, self esteem and mood
• Number of symptoms and side- effects reported, such as nausea, fatigue and pain• Intensity of symptoms reported• Duration of hospitalisation• Psychological and emotional stress• Depression and anxiety
Hayes S, et al. (2009). J Sci Med Sport;12:428-34 ; Schmitz KH, et al. (2005). Cancer Epi & Biomarkers ;14.1588-95.
Cardiovascular disease
Osteoporosis
Diabetes
Hypertension
Other cancers
Improves cancer survival: 4-18%
Exercise and survival following cancer
Exercise prescription guidelines
Feasibility and clinical concerns
• Participation in exercise post-diagnosis is feasible
• Clinical concerns:– Immunosuppressive effect of exercise– Potential for exacerbating treatment-
related side effects such as fatigue, lymphoedema, nausea, pain
– Reduced exercise tolerance in cancer survivors
• Exercise is considered to be safe• Adverse effects have been rare and mild
State of play
Majority enter cancer diagnosis insufficiently active
Majority stop exercising or experience declines in physical activity levels during treatment
Majority never regain pre-cancer physical activity levels
Cancer diagnosis
Limits to our knowledge
• Evidence heavily derived from studying women with breast cancer
• Small samples with response bias– Representativeness?– Conservative estimate of effect
• Lack of understanding of mechanisms– Focus on specific outcomes in isolation
• Cost-effectiveness• Survival
Exercise and Gynaecological Cancer
Significant scope for advancing knowledge
Name: ECHO Trial
Design: a phase III, RCT evaluating the effects of an exercise intervention during chemotherapy for ovarian cancer
Outcomes: physical wellbeing, chemotherapy-related side effects and adherence, physical function, QoL, progression-free survival, health resource use.
Team: Hayes, Friedlander, Obermair, Mileshkin, Janda, Gordon, Barnes, Beesley, Sommeijer, Martyn
App#: 1063509
Greatest challenge in exercise intervention trials is recruitment:
Need for clinician support